Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? - Wikidata - wikimedia - TriplyDB

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

http://www.wikidata.org/entity/Q28240919

about

Everolimus-eluting stents in interventional cardiology Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention Bioresorbable scaffolds: current evidence and ongoing clinical trials Optical coherence tomography: from research to practice Recent advances in drug eluting stents Nanoporous CREG-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence Very late thrombosis after implantation of sirolimus eluting stent Late acute thrombosis after implantation of sirolimus-eluting stent to treat in-stent restenosis Drug-eluting stent: a review and update Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement Safety and efficacy of biodegradable drug-eluting vs. bare metal stents: a meta-analysis from randomized trials Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis Can Platforms Affect the Safety and Efficacy of Drug-Eluting Stents in the Era of Biodegradable Polymers?: A Meta-Analysis of 34,850 Randomized Individuals Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention Advances in stent technologies and their effect on clinical efficacy and safety Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment Applications of optical coherence tomography in cardiovascular medicine, Part 2 Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios Experience with biodegradable polymer coated sirolimus-eluting coronary stent system in "real-life" percutaneous coronary intervention: 24-month data from the manipal-s registry Biodegradable Cable-Tie Rapamycin-eluting Stents.Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry One-year outcomes following drug-eluting balloon use for coronary ostial restenosis.Clinical use of optical coherence tomography to identify angiographic silent stent thrombosis Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Miniaturized self-expanding drug-eluting stent in small coronary arteries: late effectiveness.A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy.Safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent in an all-comers population cohort.Drug-eluting stents Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize In-stent restenosis exacerbated by drug-induced severe eosinophilia after second-generation drug-eluting stent implantation.Modeling and analysis of drug-eluting stents with biodegradable PLGA coating: consequences on intravascular drug delivery A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronar Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents A prospective, multi-centric, observational registry to evaluate performance of Excel™ DES in 'real world, all comers' patient population.

P2860

Q24630321-11EC7544-5027-4D38-8A91-514DC5D63E2F Q24815293-3F082088-FAA3-41A5-8D5B-F116DE00D4B5 Q26766579-843456BA-4E5A-4D60-8A81-3BDE663FDAF6 Q26863627-D8B6141F-38B2-4CD0-9FB6-AD1D46206B68 Q26991471-BCF74B91-0323-40FF-A5DD-52199DD5F3AB Q27025538-A22106DD-F196-4C37-A514-D5AD1A054AD2 Q27329486-EBC6F9F1-AAFF-445F-95F2-39E4F6398D35 Q28067509-A2450BCE-C189-4538-96A0-1EDF898E328B Q28175480-10406E45-6F61-49D1-A631-9C42AA341995 Q28199944-B1E8B67B-08FB-454B-99C8-4C1F77AE7C2D Q28219254-64794396-DA94-491F-830A-6D3139353A12 Q28222520-CDFA7CF2-F1E6-4314-B71F-9C9654B2E5B4 Q28476506-1EFE334E-8D67-4BA3-A698-601D86D6E9A4 Q28539865-138518D3-C098-44F0-9D80-D40A92000EF1 Q28545192-64F5B966-139C-49A2-B0B1-BA005AD7507E Q28551120-D1F1323E-138D-4134-8992-399D55CEC91A Q28654633-A6B7DE7B-2919-4957-838E-75FF48D4AC60 Q28972437-D2EA4952-A864-498C-BD57-7347A912F6C1 Q30234397-8EE050CE-999F-48F7-8461-B25C8C89D51C Q30417079-B1B1351D-A494-402F-8CFB-1E589EF13135 Q30619558-CA08E562-F057-49C8-891E-59F48FD689F8 Q30687588-15203D8B-EDBD-4E01-B556-D03A572D04E2 Q30849379-C71F8DC8-256D-4A8E-B551-28A590EED120 Q33437306-4668BF63-D7F3-4227-B6ED-29B159B8AAF9 Q33718232-702369F7-BEF4-42ED-91E6-EB583364408C Q33761633-DDE953C1-EEE2-4EC9-9CC6-A55CBB95575A Q33820841-D686B51D-2070-4D1F-AE02-36C1AFAB728D Q33839384-CEEE7A75-90CA-479C-88A7-8653BAFA3C12 Q33843405-6428754D-405E-4F82-A008-FDD7ED1B040B Q33854333-13961157-2083-4CCA-861E-FAD783AB71A5 Q33992746-968DF86D-60A9-4E39-B0BD-1ABC844893A0 Q34002205-C8C9C3FE-ABB6-463C-968C-B408601F2746 Q34091036-C44C050E-308B-4366-B861-549EE8120058 Q34207990-D210F527-9E66-4F21-9AA8-D2FAD31E2D3E Q34211490-0350CEFB-02C3-48F8-8AA2-FBFE0F3F96B7 Q34272872-892D6762-CA53-4A6F-B96B-F7BF65EF4C27 Q34354151-36BC7F7D-EFEE-4041-BE9A-2791B2E47291 Q34432576-7986E7D4-FA54-4CED-9C43-C3951596D73F Q34977258-B77AE6B9-325B-4245-BA2A-435BD89790E8 Q35028661-24B5520A-1E9E-4DF3-B630-0200B894259E

P2860

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

http://www.wikidata.org/entity/Q28240919

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Localized hypersensitivity and ...... stent: should we be cautious?

@ast

Localized hypersensitivity and ...... stent: should we be cautious?

@en

Localized hypersensitivity and ...... stent: should we be cautious?

@nl

type

label

Localized hypersensitivity and ...... stent: should we be cautious?

@ast

Localized hypersensitivity and ...... stent: should we be cautious?

@en

Localized hypersensitivity and ...... stent: should we be cautious?

@nl

prefLabel

Localized hypersensitivity and ...... stent: should we be cautious?

@ast

Localized hypersensitivity and ...... stent: should we be cautious?

@en

Localized hypersensitivity and ...... stent: should we be cautious?

@nl

P1433

Q28240919-19D90593-9A67-40EB-AD16-0713D204A6DB

P1476

Q28240919-D18F7ED7-2AC2-41FA-9EFA-463231002E98

P2093

Q28240919-273370B8-A906-4204-B392-74D9FFFB727D

Q28240919-2A21B2C5-8A32-4851-8BC0-D3F3A586132D

Q28240919-34AE0185-15D4-482F-9564-D828DF712012

Q28240919-70220FE6-77EA-42EF-B47B-830FE2208B90

Q28240919-7FFD4956-3C75-40B9-9F00-5B3373790F8B

Q28240919-8AE1F203-47ED-4EE2-8E96-A5644A6C9B33

Q28240919-9208A06E-9FAF-4D01-BCA2-BD5625C368C1

Q28240919-9CAA8B8E-CDCC-4B57-B6EF-8834A25AB494

Q28240919-B86A306D-CF18-4EF3-86F9-A4628A880D37

Q28240919-C359E5B9-F20A-4852-9062-E96BDFBE1092

P304

Q28240919-E5C8F254-B02C-41D2-A6B8-14F73D77650C

P31

Q28240919-5A2F364E-A90C-4F9A-98D4-048AEB138F12

P3181

Q28240919-67A62599-CEF9-42A1-AF86-FBC2E2E30747

P356

Q28240919-05C1CC53-A138-46D1-A766-E5B3585CB91C

P407

Q28240919-2FB8222A-3AAD-4DC1-85DF-24DAA85A6B81

P433

Q28240919-9E57D543-9012-465F-A337-6F394893B7B2

P478

Q28240919-73057417-2632-4431-8827-D0F86D9207B9

P577

Q28240919-B283238C-B5DD-4446-9E4F-250FB116CDE7

P5875

Q28240919-7FA4EE4B-6D97-4237-99BC-A39EEE9DBA6F

P698

Q28240919-22FFF9DD-6225-414F-ABC0-A598F4D428D2

P921

Q28240919-ACF4F631-E335-422F-996B-67AF54BE0CE0

P3181

P356

01.CIR.0000116202.41966.D4

P1433

P1476

Localized hypersensitivity and ...... stent: should we be cautious?

@en

P2093

Andrew Farb

http://www.w3.org/2001/XMLSchema#string

Frank D Kolodgie

http://www.w3.org/2001/XMLSchema#string

Giulio Guagliumi

http://www.w3.org/2001/XMLSchema#string

Giuseppe Musumeci

http://www.w3.org/2001/XMLSchema#string

Laurian Mihalcsik

http://www.w3.org/2001/XMLSchema#string

Maurizio Tespili

http://www.w3.org/2001/XMLSchema#string

Niccolo Grieco

http://www.w3.org/2001/XMLSchema#string

Orazio Valsecchi

http://www.w3.org/2001/XMLSchema#string

Renu Virmani

http://www.w3.org/2001/XMLSchema#string

Teresio Motta

http://www.w3.org/2001/XMLSchema#string

P304

701-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

817005

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.CIR.0000116202.41966.D4

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8901619

http://www.w3.org/2001/XMLSchema#string

P698

14744976

http://www.w3.org/2001/XMLSchema#string

P921